摘要
目的：观察对慢性阻塞性肺疾病患者采用支气管扩张剂治疗的临床效果。方法依据纳入排除标准共选取106例患者并随机分为两组，对照组给予倍氯米松治疗，研究组给予倍氯米松＋沙美特罗治疗；比较两组患者的肺部指标的情况，包括一秒用力呼气容积、用力肺活量和一秒用力呼气容积占用力肺活量的百分比以及观察患者的临床疗效。结果研究组患者的三项指标：一秒用力呼气容积、用力肺活量、一秒用力呼气容积占用力肺活量的百分比（1秒率）分别为（1．6±0．8）L，（3．4±0．4）L，（48．6±2．3）％，均较对照组有明显升高，差异均有统计学意义（P ＜0．05）；研究组患者的治疗总有效率为96．3％，高于对照组患者的治疗总有效率81．2％，差异有统计学意义（P ＜0．05）。结论使用糖皮质激素＋支气管扩张剂治疗慢性阻塞性肺疾病临床效果较佳，既可有效改善患者一秒用力呼气容积、用力肺活量、一秒用力呼气容积占用力肺活量的百分比，又可避免病情发展，显著提高治疗有效率，值得临床推广使用。
Objective To discuss clinical effect of bronchodilator treatment on patients with chronic obstruc-tive pulmonary disease.Methods According to the exclusion criteria,106 patients were selected and randomly divid-ed into two groups,the control group were given glucocorticoid therapy,the study group was given glucocorticoid ＋bronchodilator treatment;lung index,including forced expiratory volume in one second,forced vital capacity,and the percentage of forced expiratory volume in one second of forced vital capacity of the two groups were compared,and the patientˊs clinical curative effect was observed.Results The patients of the study group of three indicators：forced expiratory volume in one second,forced vital capacity,forced expiratory volume in one second of forced vital capacity percentage were （1.6 ±0.8）L,（3.4 ±0.4）L,（48.6 ±2.3）%,which were higher than those of the control group, the differences were statistically significant （P 〈0.05）;The total effective rate of the study group was 96.3%,which was higher than 81.2% of the control group,the difference was statistically significant （P 〈0.05）.Conclusion The clinical effect of glucocorticoid ＋bronchodilator on patients with chronic obstructive pulmonary disease is good,which can effectively improve patient forced expiratory volume in one second,forced vital capacity,forced expiratory volume in one second percentage of forced vital capacity,and can avoid illness development,significantly improve the treat-ment efficiency.
出处
《中国基层医药》
CAS
2015年第12期1832-1834,共3页
Chinese Journal of Primary Medicine and Pharmacy
关键词
肺疾病
慢性阻塞性
支气管扩张剂
临床效果
Chronic obstructive pulmonary disease
Bronchodilator
Clinical effect
